FridayJun 07, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Set to Revolutionize Rodent Pest Control for Everyday Consumers Following Amazon Store Launch

American-based SenesTech, rodent fertility control product provider, growing rapidly with its highly successful and unmatched rodent control technology, is now expanding from government and business markets to the direct consumer market with the launch of its dedicated online store on Amazon This brings SenesTech and its products closer to consumers in what its management notes will help drive growth in its fertility solutions for many years to come, and carving out a significant market share in an industry that currently posts over $1 billion in sales annually Amazon’s addition follows SenesTech’s recent multiple overseas distribution deals which opened it up…

Continue Reading

ThursdayMay 23, 2024 2:05 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Participation at Upcoming Lytham Partners Spring 2024 Investor Conference

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is announcing participation at the Lytham Partners Spring 2024 Investor Conference. The event will take place virtually on Thursday, May 30, 2024. Joel Fruendt, CEO of SenesTech, and Tom Chesterman, CFO of SenesTech, will participate in a webcasted presentation scheduled for 11:45 a.m. ET. The webcast will also be available for replay following the event. SenesTech’s management will also host virtual one-on-one meetings with investors throughout the event. See the announcement for information about how to arrange a one-on-one meeting with management. To view the presentation, visit…

Continue Reading

ThursdayMay 23, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Releases Q1 2024 Financial Results Reflecting ‘Outstanding Growth’

SenesTech reported record Q1 2024 revenue of $415,000, an increase of 78% compared to Q1 2023 and a 41% sequential increase from Q4 2023 The company attributes this growth to the introduction in January 2024 of Evolve(TM), its soft-bait product featuring breakthrough, next-generation technology that targets rat populations by using non-lethal methods to restrict fertility SenesTech is anticipating additional growth following the completion of an efficacy study providing data requested by certain state and international regulators, as this could open new markets that were previously inaccessible In May, the company also launched Evolve(TM) Mouse, a soft-bait product to control mouse…

Continue Reading

FridayMay 17, 2024 11:35 am

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Offering Proven Way to Reduce Rat Populations by over 90%

SenesTech (NASDAQ: SNES), the inventor of the only EPA-registered contraceptive for male and female rats, recognizes the risks associated with growing rodent populations in cities and areas with a substantial human population. “With its fertility control products, SenesTech offers a proven way for entire cities and urban areas to reduce rat populations by over 90%. Available in a variety of delivery systems, SenesTech’s products allow for easy and efficient product deployment, an approach that is achieving significant acceptance in the market. SenesTech’s approach is much needed throughout the industrialized and agricultural world, particularly factoring in how rodents can directly transmit…

Continue Reading

MondayMay 13, 2024 9:00 am

SenesTech Inc. (NASDAQ: SNES) Extends Evolve(TM) Product Line with Important Launch of Evolve Mouse

SenesTech, a rodent fertility control product and service provider, just launched Evolve(TM) Mouse, a contraceptive specifically designed for mice This marks an extension of the company’s hugely successful Evolve product line, ushering its official entry into the mouse contraceptive market SenesTech looks to replicate the positive results achieved in rats while tapping into a vastly growing market that currently accounts for over $1 billion in sales annually The company began taking orders for the product on May 6, with shipment set to begin on or before May 15 SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor…

Continue Reading

FridayMay 10, 2024 12:52 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Releases Q1 2024 Report on Financial, Corporate Results

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R) products, is reporting its financial and operational results for first quarter 2024. Highlights of the report include record quarterly revenues of $415,000, up 78% from Q1 2023; Evolve(TM) becoming the company's best-selling product, making up more than 50% of this quarter’s revenue; securing distribution and agreements as well as initial purchase orders with several grain-management and open-field agricultural distributors and pest-management industry distributors; global expansion with new sales in Hong Kong, Macau, the United Arab Emirates, Singapore, Australia, New Zealand and The Netherlands; the introduction of…

Continue Reading

ThursdayMay 09, 2024 2:14 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Positioned on Heels of Multiple Distribution Deals

SenesTech (NASDAQ: SNES), a rodent fertility control solutions provider, recently announced multiple distribution deals globally in what marks a huge milestone for the company. “These deals bring YTD 2024 total revenue up more than 80% compared to YTD 2023. SenesTech also announced its foray into the European market with its distribution agreement with Q-chem, a pest control product supplier in the Netherlands. The move looks to tap into the growing demand for pest control products and services since the country first implemented an Integrated Pest Control program four years ago with the explicit goal of reducing reliance on anti-coagulant rodenticides……

Continue Reading

ThursdayMay 09, 2024 9:00 am

SenesTech Inc. (NASDAQ: SNES) Anticipates Growth in Product Demand Amid Rising Cases of Human Leptospirosis

SenesTech, a rodent fertility control product provider, is projecting an increase in demand for its Evolve(TM) Soft Bait This follows the rising cases of human leptospirosis in New York, an infection associated with exposure to rat urine Evolve offers a humane approach to controlling the rodent population, with the potential for complete elimination in 12 to 18 months Evolve contributes a significant chunk of SenesTech’s revenue, and the company projects that this will continue to be the case given recent developments SenesTech (NASDAQ: SNES), a rodent fertility control product provider, and inventor of the only EPA-registered contraceptive for male and…

Continue Reading

TuesdayMay 07, 2024 10:30 am

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Soft Bait – New York’s Answer to the Growing Rat Problem

SenesTech’s Evolve(TM) Soft Bait has been proposed to be used in New York City to control its growing rat population In a bill tabled by Upper West Side Council Member Shaun Abreu, the city will explore contraception for rats and will start with a 10-block area SenesTech’s CTO notes that the city should see close to complete elimination of the population in 12-18 months, not by just controlling the death rate, but by controlling the birth rate as well For SenesTech, this move helps affirm the superiority of its products. In addition, it serves as a sign of even bigger…

Continue Reading

FridayMay 03, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Addressing the Growing Urban Rat Population, and Associated Disease Risks, with Unique EPA-Approved Rat Contraceptives

SenesTech, a rodent fertility control company, through its ContraPest(R) and patent-pending Evolve(TM) soft bait lines, is offering an effective, humane, and safe approach to controlling rat populations, and the diseases rodents can bring with them The company’s growing success speaks to the superiority of the company’s offerings, along with the overall effectiveness of its products SenesTech (NASDAQ: SNES), the inventor of the only EPA-registered contraceptive for male and female rats, recognizes the risks associated with growing rodent populations, especially in cities and areas with a substantial human population. Following its years of experience in the field, the company understands the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered